These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2356229)

  • 21. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
    Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
    Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Threshold dose of three photosensitizers in dogs with spontaneous tumors.
    Gloi AM; Beck E
    Vet Ther; 2003; 4(3):269-78. PubMed ID: 15136988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis.
    Fabris C; Valduga G; Miotto G; Borsetto L; Jori G; Garbisa S; Reddi E
    Cancer Res; 2001 Oct; 61(20):7495-500. PubMed ID: 11606385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I clinical trial of the use of zinc phthalocyanine tetrasulfonate as a photosensitizer for photodynamic therapy in dogs.
    Borgatti-Jeffreys A; Hooser SB; Miller MA; Lucroy MD
    Am J Vet Res; 2007 Apr; 68(4):399-404. PubMed ID: 17397295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aluminum phthalocyanine tetrasulfonate in MCF-10F, human breast epithelial cells: a hole burning study.
    Milanovich N; Reinot T; Hayes JM; Small GJ
    Biophys J; 1998 May; 74(5):2680-8. PubMed ID: 9591692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of cytotoxicity of sulphonated chloroaluminium phthalocyanine on various cell systems.
    Kolárová H; Ditrichová D; Rakusan J; Jírová D
    Acta Univ Palacki Olomuc Fac Med; 1996; 140():7-9. PubMed ID: 9431686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
    Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
    J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the involvement of singlet oxygen in the photodestruction by chloroaluminum phthalocyanine tetrasulfonate.
    Agarwal R; Athar M; Bickers DR; Mukhtar H
    Biochem Biophys Res Commun; 1990 Nov; 173(1):34-41. PubMed ID: 2256924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-treatment interactions of photodynamic and radiation-induced cytotoxic lesions.
    Ramakrishnan N; Clay ME; Friedman LR; Antunez AR; Oleinick NL
    Photochem Photobiol; 1990 Sep; 52(3):555-9. PubMed ID: 2284348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo photodynamic characteristics of the near-infrared photosensitizer 5,10,15,20-tetrakis(M-hydroxyphenyl) bacteriochlorin.
    Rovers JP; de Jode ML; Rezzoug H; Grahn MF
    Photochem Photobiol; 2000 Sep; 72(3):358-64. PubMed ID: 10989607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization.
    Pope AJ; Bown SG
    J Urol; 1991 May; 145(5):1064-70. PubMed ID: 2016796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver.
    Woodhams JH; Kunz L; Bown SG; MacRobert AJ
    Br J Cancer; 2004 Aug; 91(4):788-94. PubMed ID: 15266317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Damage threshold of normal rat brain in photodynamic therapy.
    Chen Q; Chopp M; Madigan L; Dereski MO; Hetzel FW
    Photochem Photobiol; 1996 Jul; 64(1):163-7. PubMed ID: 8787009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
    Grant WE; Speight PM; MacRobert AJ; Hopper C; Bown SG
    Br J Cancer; 1994 Jul; 70(1):72-8. PubMed ID: 8018544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L; Wilson BC
    J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of threshold dose of photodynamic therapy to measure superficial necrosis.
    Ferraz RC; Ferreira J; Menezes PF; Sibata CH; Castro e Silva O; Bagnato VS
    Photomed Laser Surg; 2009 Feb; 27(1):93-9. PubMed ID: 19250052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
    Kleemann D; MacRobert AJ; Mentzel T; Speight PM; Bown SG
    Br J Cancer; 1996 Jul; 74(1):49-58. PubMed ID: 8679457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phthalocyanine fluorescence in tumors during PDT.
    Moan J; Anholt H
    Photochem Photobiol; 1990 Mar; 51(3):379-81. PubMed ID: 2356234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
    Huang Y; Xu G; Peng Y; Lin H; Zheng X; Xie M
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.